IndraLab

Statements


BRAF binds EGFR, ALK, and KRAS. 1 / 1
| 1

sparser
"Companion diagnostics for hotspot mutations of EGFR, KRAS, BRAF, and ALK, which are clinically associated with specific targeted cancer therapies, are currently available for LUADs [ xref ]."